OBAGI SKINTRINSIQ CLARIFIYING PROTOCOL
salicylic acid, titanium dioxide, and zinc oxide kit |
| Product Information |
| Product Type | HUMAN OTC DRUG | Item Code (Source) | NDC: 62032-909 |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 62032-909-09 | 1 in 1 BOX | 08/01/2021 | |
|
| Quantity of Parts |
| Part # | Package Quantity | Total Product Quantity |
| Part 1 | 1 BOTTLE, PLASTIC | 60 mL |
| Part 2 | 1 BOTTLE, PLASTIC | 59 mL |
| Part 3 | 1 BOTTLE, PLASTIC | 148 mL |
| Part 4 | 1 BOTTLE, PUMP | 48 g |
| Part 5 | 1 TUBE | 85 g |
|
| Part 1 of 5 |
OBAGI NU-DERM GENTLE CLEANSER
cleansing (cold creams, cleansing lotions, liquids, and pads) [skin care preparations (creams, lotions, powder, and sprays)] gel |
|
| Product Information |
| Route of Administration | TOPICAL |
|
|
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | | 60 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| Cosmetic | | 08/01/2021 | |
|
| Part 2 of 5 |
OBAGI NU-DERM TONER
face and neck (excluding shaving preparations), leave-on [skin care preparations (creams, lotions, powder, and sprays)] liquid |
|
| Product Information |
| Route of Administration | TOPICAL |
|
|
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | | 59 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| Cosmetic | | 08/01/2021 | |
|
| Part 3 of 5 |
CLENZIDERM PORE THERAPY
ACNE TREATMENT
salicylic acid liquid |
|
| Product Information |
| Item Code (Source) | NDC: 62032-612 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) | SALICYLIC ACID | 20 mg in 1 mL |
|
|
|
| Product Characteristics |
| Color | purple | Score | |
| Shape | | Size | |
| Flavor | | Imprint Code | |
| Contains | |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 62032-612-04 | 148 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph drug | M006 | 08/01/2021 | |
|
| Part 4 of 5 |
OBAGI HYDRATE FACIAL MOISTURIZER
moisturizing [skin care preparations (creams, lotions, powder, and sprays)] lotion |
|
| Product Information |
| Route of Administration | TOPICAL |
|
|
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | | 1 in 1 CARTON | | |
| 1 | | 48 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| Cosmetic | | 08/01/2021 | |
|
| Part 5 of 5 |
SUN SHIELD MINERAL BROAD SPECTRUM SPF 50
SUNSCREEN
titanium dioxide and zinc oxide lotion |
|
| Product Information |
| Item Code (Source) | NDC: 62032-811 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) | TITANIUM DIOXIDE | 6.2 g in 100 g |
| ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) | ZINC OXIDE | 15.6 g in 100 g |
|
|
|
| Product Characteristics |
| Color | white | Score | |
| Shape | | Size | |
| Flavor | | Imprint Code | |
| Contains | |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 62032-811-09 | 1 in 1 CARTON | | |
| 1 | | 85 g in 1 TUBE; Type 0: Not a Combination Product | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph drug | M020 | 08/01/2021 | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph drug | M020 | 08/01/2021 | |
|